How does the hemoglobin electrophoresis pattern in beta thalassemia differ from that of a normal adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hemoglobin Electrophoresis in Beta Thalassemia vs Normal

Beta thalassemia shows elevated HbA2 (typically >3.6-4.0%) and often elevated HbF, while normal adults have HbA2 of 2.5-3.5% and HbF <1%.

Normal Adult Pattern

In normal adults, hemoglobin electrophoresis demonstrates 1:

  • HbA: 95-98% (α2β2 chains)
  • HbA2: 2.5-3.5% (α2δ2 chains)
  • HbF: <1% (α2γ2 chains)

Specific studies using capillary electrophoresis show normal HbA2 ranges of 2.61-2.88% and HbF of 0.03-0.58% 2, 3.

Beta Thalassemia Carrier (Heterozygous) Pattern

The hallmark diagnostic feature is elevated HbA2, which serves as the most reliable marker for beta thalassemia trait 4:

  • HbA2: 4.0-7.0% (typically 4.62-6.04% depending on method) 4
  • HbF: Variable - may be normal (<1%) or mildly elevated (1-5%)
  • HbA: Decreased proportionally to accommodate elevated HbA2

Critical Distinctions Between β0 and β+ Phenotypes

Recent data shows important differences 5:

β0-thalassemia carriers:

  • HbA2 ≥5.0%
  • Hemoglobin ≤11.0 g/dL
  • MCV ≤64.0 fL
  • MCH ≤19.0 pg
  • More severe microcytosis and anemia

β+-thalassemia carriers:

  • HbA2 typically 3.6-5.0%
  • Less severe hematological changes
  • Higher hemoglobin, MCV, and MCH values

Beta Thalassemia Major (Homozygous) Pattern

In transfusion-dependent thalassemia major 6:

  • Severe reduction or absent HbA production
  • Markedly elevated HbF (often the predominant hemoglobin)
  • Variable HbA2 (may be normal, elevated, or decreased depending on transfusion status)
  • Excess α-globin chains cause ineffective erythropoiesis

Important Clinical Caveats

Age-Related Considerations

In infants under 6 months, hemoglobin electrophoresis may be misleading 7:

  • Normal fetal hemoglobin is still elevated physiologically
  • HbA2 levels may not yet be diagnostic
  • Molecular genetic testing is essential for definitive diagnosis in this age group

Masking Effects

Several conditions can obscure the typical beta thalassemia pattern 7, 8:

  1. Co-inheritance with α-thalassemia: Can normalize HbA2 levels, making electrophoresis nondiagnostic
  2. Hemoglobin variants: Hb variants with HbA2 ≥3.6% and/or HbF ≥5.0% are frequently misinterpreted as beta thalassemia (odds ratio 7.3-18.2) 8
  3. Iron deficiency: Can falsely lower HbA2, masking beta thalassemia trait

Method-Specific Variations

Different analytical methods yield slightly different reference ranges 4:

  • Chromatographic methods: HbA2 2.76% (normal) vs 4.62% (beta thal)
  • Capillary electrophoresis: HbA2 2.61% (normal) vs 5.82% (beta thal)
  • Cellulose acetate: HbA2 2.8% (normal) vs 6.04% (beta thal)

When electrophoresis shows borderline or atypical results, proceed directly to molecular genetic testing rather than relying solely on hemoglobin quantification 7, 9.

Diagnostic Algorithm

For suspected beta thalassemia 9, 10:

  1. Initial screening: Complete blood count showing microcytic hypochromic anemia (MCV <80 fL, MCH <27 pg)
  2. Hemoglobin analysis: Capillary electrophoresis or HPLC
  3. If HbA2 >3.6%: Diagnose beta thalassemia trait
  4. If results equivocal or infant <6 months: Proceed to molecular testing
  5. If hemoglobin variant present: Use two different analytical methods and confirm with molecular analysis 8

References

Research

Rapid diagnosis of thalassemias and other hemoglobinopathies by capillary electrophoresis system.

Translational research : the journal of laboratory and clinical medicine, 2008

Research

Best Practices for Thalassaemia Management: Recommendations by Indian Society of Haematology and Blood Transfusion.

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.